Melvyn I Marquis
Examiner (ID: 16161)
Most Active Art Unit | 1501 |
Art Unit(s) | 1402, 1505, 1503, 1501, 1712, 2200, 1754, 1401 |
Total Applications | 2620 |
Issued Applications | 2300 |
Pending Applications | 26 |
Abandoned Applications | 294 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16253880
[patent_doc_number] => 20200263254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => METHOD FOR DETERMINING THE RESPONSE OF A MALIGNANT DISEASE TO AN IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 15/733039
[patent_app_country] => US
[patent_app_date] => 2018-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12242
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15733039
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/733039 | METHOD FOR DETERMINING THE RESPONSE OF A MALIGNANT DISEASE TO AN IMMUNOTHERAPY | Nov 3, 2018 | Pending |
Array
(
[id] => 13987383
[patent_doc_number] => 20190062849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => METHODS FOR THE SURVEILLANCE, DIAGNOSIS AND SCREENING OF BLADDER CANCER
[patent_app_type] => utility
[patent_app_number] => 16/173189
[patent_app_country] => US
[patent_app_date] => 2018-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16173189
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/173189 | Methods for the surveillance, diagnosis and screening of bladder cancer | Oct 28, 2018 | Issued |
Array
(
[id] => 16293330
[patent_doc_number] => 10770183
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-08
[patent_title] => Methods of assessing a risk of developing necrotizing meningoencephalitis
[patent_app_type] => utility
[patent_app_number] => 16/167463
[patent_app_country] => US
[patent_app_date] => 2018-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17939
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16167463
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/167463 | Methods of assessing a risk of developing necrotizing meningoencephalitis | Oct 21, 2018 | Issued |
Array
(
[id] => 14132835
[patent_doc_number] => 20190100807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => COMPOSITIONS AND METHODS FOR DETECTING MUTATIONS IN JAK2 NUCLEIC ACID
[patent_app_type] => utility
[patent_app_number] => 16/158854
[patent_app_country] => US
[patent_app_date] => 2018-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16158854
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/158854 | Compositions and methods for detecting mutations in JAK2 nucleic acid | Oct 11, 2018 | Issued |
Array
(
[id] => 15915913
[patent_doc_number] => 10655187
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/155220
[patent_app_country] => US
[patent_app_date] => 2018-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 35302
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 233
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16155220
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/155220 | Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereof | Oct 8, 2018 | Issued |
Array
(
[id] => 16238670
[patent_doc_number] => 20200255904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => DNA METHYLATION BIOMARKERS FOR CANCER DIAGNOSING
[patent_app_type] => utility
[patent_app_number] => 16/651871
[patent_app_country] => US
[patent_app_date] => 2018-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9146
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16651871
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/651871 | DNA methylation biomarkers for cancer diagnosing | Sep 30, 2018 | Issued |
Array
(
[id] => 14132795
[patent_doc_number] => 20190100787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => COMPOSITIONS AND METHODS FOR DETECTION OF TRICHOMONAS VAGINALIS
[patent_app_type] => utility
[patent_app_number] => 16/145648
[patent_app_country] => US
[patent_app_date] => 2018-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16145648
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/145648 | COMPOSITIONS AND METHODS FOR DETECTION OF TRICHOMONAS VAGINALIS | Sep 27, 2018 | Abandoned |
Array
(
[id] => 14072989
[patent_doc_number] => 20190085382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => FTCD GENOTYPE AND GENE EXPRESSION USED TO PREDICT COGNITIVE ABILITY
[patent_app_type] => utility
[patent_app_number] => 16/136669
[patent_app_country] => US
[patent_app_date] => 2018-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16136669
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/136669 | FTCD GENOTYPE AND GENE EXPRESSION USED TO PREDICT COGNITIVE ABILITY | Sep 19, 2018 | Abandoned |
Array
(
[id] => 14102947
[patent_doc_number] => 20190093149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => ASSAYS FOR DETECTING MULTIPLE TICK-BORNE PATHOGENS
[patent_app_type] => utility
[patent_app_number] => 16/130177
[patent_app_country] => US
[patent_app_date] => 2018-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18871
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16130177
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/130177 | ASSAYS FOR DETECTING MULTIPLE TICK-BORNE PATHOGENS | Sep 12, 2018 | Abandoned |
Array
(
[id] => 16112401
[patent_doc_number] => 20200208223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => IDENTIFICATION OF EPIGENETIC SIGNATURES INDICATING BREAST CANCER
[patent_app_type] => utility
[patent_app_number] => 16/643043
[patent_app_country] => US
[patent_app_date] => 2018-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16643043
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/643043 | IDENTIFICATION OF EPIGENETIC SIGNATURES INDICATING BREAST CANCER | Sep 11, 2018 | Abandoned |
Array
(
[id] => 13794023
[patent_doc_number] => 20190010550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => ULTRA-HIGH SENSITIVE MONITORING OF EARLY TRANSPLANTATION FAILURE
[patent_app_type] => utility
[patent_app_number] => 16/126683
[patent_app_country] => US
[patent_app_date] => 2018-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16126683
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/126683 | ULTRA-HIGH SENSITIVE MONITORING OF EARLY TRANSPLANTATION FAILURE | Sep 9, 2018 | Abandoned |
Array
(
[id] => 14019379
[patent_doc_number] => 20190071683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => Solute Carrier Family 14 Member 1 (SLC14A1) Variants And Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/123373
[patent_app_country] => US
[patent_app_date] => 2018-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16123373
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/123373 | Solute Carrier Family 14 Member 1 (SLC14A1) Variants And Uses Thereof | Sep 5, 2018 | Abandoned |
Array
(
[id] => 16691952
[patent_doc_number] => 20210074431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => GENE EXPRESSION SUBTYPE ANALYSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA FOR TREATMENT MANAGEMENT
[patent_app_type] => utility
[patent_app_number] => 16/642558
[patent_app_country] => US
[patent_app_date] => 2018-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -81
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642558
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/642558 | GENE EXPRESSION SUBTYPE ANALYSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA FOR TREATMENT MANAGEMENT | Aug 29, 2018 | Abandoned |
Array
(
[id] => 14868803
[patent_doc_number] => 20190284643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => MATERIALS AND METHODS FOR DETECTING SOURCE BODY FLUIDS
[patent_app_type] => utility
[patent_app_number] => 16/054210
[patent_app_country] => US
[patent_app_date] => 2018-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12622
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16054210
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/054210 | Materials and methods for detecting source body fluids | Aug 2, 2018 | Issued |
Array
(
[id] => 13902511
[patent_doc_number] => 20190040460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => METHOD FOR THE PRODUCTION AND FORGERY-PROOF AUTHENTICATION OF A MEDICAL DEVICE BY USING A NUCLEIC ACID WITH KNOWN PARTIAL SEQUENCE
[patent_app_type] => utility
[patent_app_number] => 16/044824
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8553
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16044824
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/044824 | METHOD FOR THE PRODUCTION AND FORGERY-PROOF AUTHENTICATION OF A MEDICAL DEVICE BY USING A NUCLEIC ACID WITH KNOWN PARTIAL SEQUENCE | Jul 24, 2018 | Abandoned |
Array
(
[id] => 16277119
[patent_doc_number] => 10760137
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-01
[patent_title] => Compositions and methods for detection of
[patent_app_type] => utility
[patent_app_number] => 16/031320
[patent_app_country] => US
[patent_app_date] => 2018-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 15384
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 367
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16031320
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/031320 | Compositions and methods for detection of | Jul 9, 2018 | Issued |
Array
(
[id] => 15832583
[patent_doc_number] => 20200131573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => GENETIC VARIANTS ASSOCIATED WITH HUMAN-DIRECTED HYPER-SOCIAL BEHAVIOR IN DOMESTIC DOGS
[patent_app_type] => utility
[patent_app_number] => 16/626374
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20679
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16626374
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/626374 | GENETIC VARIANTS ASSOCIATED WITH HUMAN-DIRECTED HYPER-SOCIAL BEHAVIOR IN DOMESTIC DOGS | Jun 28, 2018 | Pending |
Array
(
[id] => 13479789
[patent_doc_number] => 20180291437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => METHODS FOR DETECTING ENHANCED NMDA RECEPTOR FUNCTION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/014052
[patent_app_country] => US
[patent_app_date] => 2018-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16014052
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/014052 | METHODS FOR DETECTING ENHANCED NMDA RECEPTOR FUNCTION AND USES THEREOF | Jun 20, 2018 | Abandoned |
Array
(
[id] => 13479853
[patent_doc_number] => 20180291469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => COMPOSITIONS AND METHODS FOR PERFORMING METHYLATION DETECTION ASSAYS
[patent_app_type] => utility
[patent_app_number] => 16/013240
[patent_app_country] => US
[patent_app_date] => 2018-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21800
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16013240
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/013240 | Compositions and methods for performing methylation detection assays | Jun 19, 2018 | Issued |
Array
(
[id] => 14485717
[patent_doc_number] => 10329627
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-06-25
[patent_title] => Method for predicting and monitoring response to an immune checkpoint inhibitor
[patent_app_type] => utility
[patent_app_number] => 16/013869
[patent_app_country] => US
[patent_app_date] => 2018-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12571
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16013869
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/013869 | Method for predicting and monitoring response to an immune checkpoint inhibitor | Jun 19, 2018 | Issued |